Matinas BioPharma's total assets for Q1 2026 were $5.87M, a decrease of -18.51% from the previous quarter. MTNB total liabilities were $2.85M for the fiscal quarter, a 19.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.